Trial of Montelukast for Treatment of Acute Bronchiolitis

Completed · Not applicable · Has a placebo group

Conditions studied: Bronchiolitis

In brief

The primary rationale for this study is to evaluate the effect of once daily montelukast on duration of acute illness in infants with first-time bronchiolitis.

Key facts

Study ID

NCT00863317

Run by

Medical College of Wisconsin

People needed

141

Starts

2008-12-01

Expected to finish

2011-07-01

Last updated by the study team

2015-07-15

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female infants aged 3 to 12 months of age
• Diagnosis by emergency physician of bronchiolitis

You may not qualify if…

• Any previous episode, as determined by a physician, of wheezing, bronchiolitis or asthma
• Any history of previous bronchodilator use prior to this illness
• Treatment with corticosteroids in the 14 days prior to the current illness
• Immunosuppression
• Immunodeficiency
• Caregiver does not speak English
• Diagnosis by the treating ED physician of croup
• Diagnosis by the treating ED physician of pneumonia
• Caregiver does not have access to a telephone

Where it is running

• Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.